Clinical trial

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

NCT03811652

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-12-20

PhasePHASE1

Study timeline

Study start (actual)2018-12-20Date precision: day

Registry last updated2019-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancer Squamous (NSCLC-Sq)unresolved

Head and Neck Squamous Cell Carcinoma (HNSCC)unresolved

Small Cell Lung Cancer (SCLC)unresolved

Pancreatic Ductal Adenocarcinoma (PDAC)unresolved

Colorectal Cancer (CRC)unresolved

Metastatic Castration-resistant Prostate Cancer (mCRPC)unresolved

Interventions

Sponsors & collaborators

MedImmune LLClead sponsor

Mapped research locations

TorontoOntario, Canada1 NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03811652 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.